Connect with us

Hi, what are you looking for?

Health Care Sector

Joint Venture BioFarma Innovations Debuts in London

biofarma-innovations
Cuban-British joint venture BioFarma Innovations made its debut in the UK on Friday. Photo: Chokniti Khongchum, Pexels

Cuban-British joint venture firm BioFarma Innovations made its formal debut on Friday in London in an online seminar that featured Cuban advances in biotechnology.

According to the Cuban Embassy in the U.K., the seminar analyzed the advantages of the business partnership. Chris Bennett, President of the Caribbean Council, Lord David Triesman, Co-Chairman of the Cuba Initiative, and Merardo Pujol, Development Director of Cuba’s Heber Biotec S.A. participated in the event.

BioFarma Innovations, created August 3, 2020, is a joint venture between BioCubaFarma and the British company SG Innovations Ltd. The company will focus on the strategy of developing and commercializing BioCubaFarma’s product line of patented biopharmaceutical drugs to Europe and the British Commonwealth.

The Company plans to provide worldwide access to BioCubaFarma‘s research and development, its scientific experience and its products.

The online seminar “Bringing Cuban biopharmaceuticals to patients around the world – a new British-Cuban joint venture” also addressed the global marketing of pharmaceutical products, the protection of intellectual property and the opportunities that exist to expand the relationship and make Cuban medicines more accessible to patients around the world.

The event also presented recent Cuban scientific success and innovation in pharmaceuticals and vaccines for the treatment of COVID-19, development taking place in the context of ever-increasing sanctions by the United States.

The Cuban Chamber of Commerce and the British Embassy in Havana will organize a similar seminar on December 11.

Click to comment

You must be logged in to post a comment Login

Leave a Reply

Related News:

Health Care Sector

BioCubaFarma reported in its Twitter account that Colombia’s Ministry of Health and Protection has approved Cuba’s cancer drug CIMAher. The drug will be available...

Health Care Sector

Russia and Cuba to begin research on new cancer drug. On Wednesday the representative of BioCubaFarma in Russia and the national company Alphanil signed...

Health Care Sector

A new joint venture company, IncuBio S.A., has been established in the Mariel Special Development Zone to attract venture capital for the funding of...

Tourism

Canadian company AquaSub Scuba Diving, and Cuba’s Marina Marlin S.A. have signed a commercial contract to promote scuba diving travel to Cuba. The newly...

error: This content is copyright protected.